Impact of educational intervention on awareness of pharmacovigilance among medical undergraduates in Karnataka, India: a cross-sectional study
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20161557Keywords:
Pharmacovigilance, Educational intervention, Impact, AwarenessAbstract
Background: India being a part of national pharmacovigilance program (NPP), its contribution to UMC (Uppsala monitoring centre) is very little and pharmacovigilance program of India (PvPI) is still in its infancy. Lack of vibrant reporting culture necessitates bringing the awareness and importance of it. Objective of this study was to assess the level of knowledge, awareness, and the method of application of pharmacovigilance (PV) and to evaluate the impact of an educational intervention among second year medical students for improving awareness of pharmacovigilance.
Methods: This was a cross-sectional questionnaire based study conducted among 146 students in a tertiary care teaching hospital in B.G. Nagara, Mandya, Karnataka, India. Purpose of the study was explained to all the participants. Pretest questionnaires were distributed and filled questionnaires were collected following the educational intervention through continued medical education (CME), same questionnaire was given as post-test questionnaire. Both the test results were analysed to know the educational impact.
Results: Out of 146, a total 130 medical students were involved in pre and post-test questionnaire. The overall response rates between pre and post intervention had improved in majority of the medical undergraduates which brings out the effectiveness of intervention for improving the reporting system.
Conclusions: Educational intervention was more effective in improving student’s knowledge, awareness and applications of pharmacovigilance. Early sensitization through educational interventions in II phase of MBBS itself enhances the reporting frequency in future through their active participation & emphasizing the need to design the suitable strategies to develop vibrant as well as voluntary reporting culture.
References
WHO pharmacovigilance. Available at www.who.int/medicines /areas/quality_safety/safety_ efficacy/pharmvigi/en/. Assessed 27 January 2016.
World Health Organization. Requirements for adverse reaction reporting. Geneva, Switzerland: World Health Organization; 1975.
Baniasadi SH, Fahimi F, Shalviri G. Developing an adverse drug reaction reporting system at a teaching hospital. Basic Clin Pharmacol Toxicol. 2008;102:408-11.
Sultana J, Cutroneo P, Trifirò G. Clinical and economic burden of adverse drug reactions. J Pharmacol Pharmacother. 2013;4(1):73-7.
Green CF, Mottram DR, Rowe PH, Pirmohamed M. Attitudes and knowledge of hospital pharmacists to adverse drug reaction reporting. Br J Clin Pharmacol. 2001;51:81-6.
Feely J, Moriarty S, O’Connor P. Stimulating reporting of adverse drug reactions by using a fee. BMJ. 1990;300:22-3.
Prerna U, Vikas S, Vijay VM, Monika S, Mushtaq A. Knowledge of adverse drug reaction reporting in first year postgraduate doctors in a medical college. Ther Clin Risk Manag. 2012;8(1):307-12.
Irujo M, Beitia G, Bes-Rastrollo M, Figueiras A, Hernández DS, Lasheras B. Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region. Drug Saf. 2007;30(11):1073-82.
Joseph LR, Palappallil DS. Impact of a simple educational intervention on the knowledge and awareness of pharmacovigilance among medical undergraduate students. Int J Med Phar Sci. 2015;6(3):5-9.
Sanghavi DR, Dhande PP, Pandit VA. Perception of pharmacovigilance among doctors in a tertiary care hospital: influence of an interventional lecture. Int J Risk Saf Med. 2013;25:197-204.
Hardeep, Bajaj JK, Kumar R. A survey on the knowledge, attitude and the practice of pharmacovigilance among the health care professionals in a teaching hospital in Northern India. J Clin Diagn Res. 2013;7:97-9.
Tabali M, Jeschke E, Bockelbrink A, Witt CM, Willich SN, Ostermann T, et al. An educational intervention to improve the physician reporting of the adverse drug reactions (ADRs) in a primary care setting in the complementary and alternative medicine programs. BMC Public Health. 2009;9:274.
